Catalent Clinical Supply Content
-
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Risk Mitigation In Direct-To-Patient Clinical Trials
The DTP model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to overall study timelines and budgets. Explore how to ease trial troubles through DTP studies.
-
Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk
Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns must be identified and addressed.
-
Optimizing Cell Therapy Supply Chains For Success
When it comes to transporting highly sensitive and valuable materials, such as cell therapies, learn how teams can ensure that unique storage and distribution requirements are met.
-
Integrating Early Development With Clinical Supply
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
-
Designing An Optimal APAC Clinical Supply Chain
Learn how to navigate the complex clinical supply distribution landscape within this important and growing region.
-
Optimizing Resupply To Reduce Risk Of Late Phase Delays
Early collaboration with a clinical supply manager can help proactively negotiate potential pitfalls. Learn efficient resupply practices and execute successful supply chain strategies.
-
Commercial Drug Sourcing For Clinical Trials
Learn how the right partner can leverage years of experience, market knowledge, industry relationships, and clinical packaging expertise to develop a sourcing strategy tailored to the needs of each study.
-
Impact Of Supplier Choice On APAC Clinical Trial Execution
Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.
-
Making The Case For Case Management For Cell And Gene Therapies
It is crucial to ensure that CGT supply chain risks are mitigated, as well as to have proactive strategies in place to address unforeseen challenges before they become an issue.